Cutilli, T <br/><br/>
p53 tumor suppressor protein and H-RAS oncogene in maxillofacial tumors: immunohistochemical and genetic investigation, induction chemotherapy response and prognosis evaluation.  [electronic resource] 

 -  Journal of chemotherapy (Florence, Italy)  Oct 1998 
 - 411-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1120-009X 
<br/><br/><label>Standard No.: </label>10.1179/joc.1998.10.5.411  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Facial Neoplasms--drug therapy<br/>Fluorouracil--administration & dosage<br/>Genes, ras<br/>Humans<br/>Immunohistochemistry<br/>Jaw Neoplasms--drug therapy<br/>Mutation<br/>Neoadjuvant Therapy<br/>Prognosis<br/>Treatment Outcome<br/>Tumor Suppressor Protein p53--biosynthesis